Recruiting Heart Disease Studies in Durham
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are...
PK/PD of Digoxin in Infants With SVHD
The primary participant will be an infant with single ventricle heart disease. This is a research study to learn more about how the medication digoxin, which is routinely prescribed to infants and ch...
About Heart Disease Clinical Trials in Durham
Heart disease is the leading cause of death worldwide, encompassing conditions that affect the heart and blood vessels. Coronary artery disease, the most common type, occurs when arteries supplying the heart become narrowed or blocked. Risk factors include high blood pressure, high cholesterol, diabetes, and smoking.
There are currently 2 heart disease clinical trials recruiting participants in Durham, NORTH%20CAROLINA. These studies are seeking a combined 720 participants. Research is being sponsored by VA Office of Research and Development, Duke University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Disease Clinical Trials in Durham — FAQ
Are there heart disease clinical trials in Durham?
Yes, there are 2 heart disease clinical trials currently recruiting in Durham, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Durham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Durham research site will contact you about next steps.
Are clinical trials in Durham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Durham studies also compensate for your time and travel.
What heart disease treatments are being tested?
The 2 active trials in Durham are testing new therapies including novel drugs, biologics, and treatment approaches for heart disease.
Data updated March 2, 2026 from ClinicalTrials.gov